Preparation For DNA Replication: The Key To A Successful S Phase

Home » What Is The S Phase » Preparation For DNA Replication: The Key To A Successful S Phase

Maybe your like

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

Successful genome duplication is required for cell proliferation and demands extraordinary precision and accuracy. The mechanisms by which cells enter, progress through, and exit S phase are intense areas of focus in the cell cycle and genome stability fields. Key molecular events in the G1 phase of the cell division cycle, especially origin licensing, are essential for pre-establishing conditions for efficient DNA replication during the subsequent S phase. If G1 events are poorly regulated or disordered, then DNA replication can be compromised leading to genome instability, a hallmark of tumorigenesis. Upon entry into S phase, coordinated origin firing and replication progression ensure complete, timely, and precise chromosome replication. Both G1 and S phase progressions are controlled by master cell cycle protein kinases and ubiquitin ligases that govern the activity and abundance of DNA replication factors. In this short review, we describe current understanding and recent developments related to G1 progression and S phase entrance and exit with a particular focus on origin licensing regulation in vertebrates.

Keywords: DNA replication; cell cycle; checkpoint; genome stability; origin licensing; replication stress.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.. Illustrations of normal and abnormal…

Figure 1.. Illustrations of normal and abnormal origin licensing outcomes.

A. Normal origin licensing and…

Figure 1.. Illustrations of normal and abnormal origin licensing outcomes. A. Normal origin licensing and CDK2-dependent firing in G1 and S phase. B. Unscheduled licensing and firing leading to re-replication and genome instability. C. Underlicensing in G1 leading to replication stress and genome instability.
Figure 2.

Figure 2.. Origin licensing.

The concerted action…

Figure 2.. Origin licensing.

The concerted action of ORC, CDC6, and CDT1 load hexamers of…

Figure 2.. Origin licensing. The concerted action of ORC, CDC6, and CDT1 load hexamers of MCM onto DNA during G1 phase. A loaded MCM double hexamer constitutes a licensed origin; See also the text box.
Figure. 3.

Figure. 3.. Progression through G1 and S…

Figure. 3.. Progression through G1 and S phase represented as a roller-coaster track.

Major decision…

Figure. 3.. Progression through G1 and S phase represented as a roller-coaster track. Major decision points in G1 and at the G1/S transition are indicated in yellow, and a cell cycle checkpoint at or just prior to the G1/S transition is marked in green.
See this image and copyright information in PMC

References

    1. Morgan DO (2007) The Cell Cycle: Principles of Control, OUP/New Science Press.
    1. O’Farrell PH (2011) Quiescence: early evolutionary origins and universality do not imply uniformity. Philos Trans R Soc Lond B Biol Sci. 366, 3498–3507. - PMC - PubMed
    1. Terzi MY, Izmirli M & Gogebakan B (2016) The cell fate: senescence or quiescence. Mol Biol Rep. 43, 1213–1220. - PubMed
    1. Aguilera A & Garcia-Muse T (2013) Causes of genome instability. Annu Rev Genet. 47, 1–33. - PubMed
    1. Riera A, Tognetti S & Speck C (2014) Helicase loading: how to build a MCM2–7 double-hexamer. Semin Cell Dev Biol. 30, 104–109. - PubMed
Show all 120 references

Publication types

  • Research Support, N.I.H., Extramural Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Research Support, Non-U.S. Gov't Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Review Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

MeSH terms

  • Animals Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Carcinogenesis / genetics Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Carcinogenesis / metabolism Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Carcinogenesis / pathology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Cell Cycle / genetics Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Cell Cycle Checkpoints / genetics Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Cyclin-Dependent Kinases / genetics* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Cyclin-Dependent Kinases / metabolism Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • DNA Replication* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Eukaryotic Cells / cytology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Eukaryotic Cells / metabolism Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • G1 Phase / genetics* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Gene Expression Regulation Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Genome* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Genomic Instability Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Humans Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • S Phase / genetics* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Signal Transduction Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Ubiquitin-Protein Ligases / genetics* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Ubiquitin-Protein Ligases / metabolism Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

Substances

  • Ubiquitin-Protein Ligases Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Cyclin-Dependent Kinases Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

Grants and funding

  • R01 GM083024/GM/NIGMS NIH HHS/United States
  • T32 GM007040/GM/NIGMS NIH HHS/United States
  • HHMI/Howard Hughes Medical Institute/United States
  • R25 GM055336/GM/NIGMS NIH HHS/United States
  • GT10886/HHMI Gilliam Fellowship for Advanced Study/International
  • R01 GM102413/GM/NIGMS NIH HHS/United States
  • HHMI/Howard Hughes Medical Institute/United States
Show all 7 grants

LinkOut - more resources

  • Full Text Sources

    • Europe PubMed Central
    • Ovid Technologies, Inc.
    • PubMed Central
    • Wiley

Tag » What Is The S Phase